Predicting Prostate Cancer Progression During Active Surveillance Using Longitudinal bpMRI Scans and A Multi-scale Foundation Model

Published: 27 Mar 2025, Last Modified: 01 May 2025MIDL 2025 PosterEveryoneRevisionsBibTeXCC BY 4.0
Keywords: Prostate Cancer Diagnosis, Active Surveillance, Foundation Model, Longitudinal bpMRI
Abstract: Active Surveillance (AS) is the recommended management strategy for patients with low- or intermediate-risk Prostate Cancer (PCa), providing a safe alternative that helps avoid the adverse effects of overtreatment. While artificial intelligence (AI)-based models for PCa detection have been extensively studied, their application in AS remains challenging, with limited research addressing the detection of PCa progression in AS scenarios. In this study, we present a novel framework for predicting PCa progression within AS protocols using bi-parametric MRI (bpMRI). Due to the limited availability of longitudinal bpMRI scans (206 patients in our study), we first developed a multi-scale foundation model trained on a large cohort of single-year bpMRI scans, comprising 5,162 patients from 10 different institutions. Building on this foundation, we designed a three-module framework: (1) a lesion detection module to identify PCa lesions in full bpMRI scans, (2) a lesion classification module to perform detailed analysis of the identified lesion regions, and (3) a multi-scan lesion progression prediction module to assess changes in lesions over time using longitudinal bpMRI patches. The proposed framework was evaluated on a cohort from an AS clinical trial and demonstrated significant performance improvements over baseline models and radiologists, highlighting its potential to enhance clinical decision-making in AS management.
Primary Subject Area: Detection and Diagnosis
Secondary Subject Area: Application: Radiology
Paper Type: Both
Registration Requirement: Yes
Submission Number: 200
Loading

OpenReview is a long-term project to advance science through improved peer review with legal nonprofit status. We gratefully acknowledge the support of the OpenReview Sponsors. © 2025 OpenReview